Literature DB >> 16372141

Percutaneous myocardial ablation for left mid-ventricular obstructive hypertrophic cardiomyopathy.

I Tengiz1, E Ercan, U O Türk.   

Abstract

Mid-ventricular obstructive hypertrophic cardiomyopathy (MVOHC) is a rare type of cardiomyopathy. The diagnosis is based on the hourglass appearance on the left ventriculogram and the presence of pressure gradient between apical and basal chamber of the ventriculum on the hemodynamic assessment. Atrio-ventricular sequential pacing and alcohol ablation have been proposed as less invasive alternatives to surgery for patients who fail to respond to pharmacologic therapy. The present case represents successful percutaneous treatment with alcohol ablation to patient with MVOHC and apical aneurysm. Alcohol ablation to distal segment of the left anterior descending artery resulted with relief of clinical symptoms and intra-ventricular pressure gradient.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16372141     DOI: 10.1007/s10554-005-5295-8

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  15 in total

1.  Beneficial effect of dual-chamber pacing for a left mid-ventricular obstruction with apical aneurysm.

Authors:  Hiroyuki Watanabe; Satoshi Kibira; Takashi Saito; Hiroshi Shimizu; Toyohiko Abe; Ichirota Nakajima; Kenji Iino; Mamoru Miura
Journal:  Circ J       Date:  2002-10       Impact factor: 2.993

2.  Hypertrophic cardiomyopathy with left ventricular apical diverticulum.

Authors:  B J Maron; R G Hauser; W C Roberts
Journal:  Am J Cardiol       Date:  1996-06-01       Impact factor: 2.778

3.  Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial.

Authors:  R A Nishimura; J M Trusty; D L Hayes; D M Ilstrup; D R Larson; S N Hayes; T G Allison; A J Tajik
Journal:  J Am Coll Cardiol       Date:  1997-02       Impact factor: 24.094

4.  Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.

Authors:  H Seggewiss; U Gleichmann; L Faber; D Fassbender; H K Schmidt; S Strick
Journal:  J Am Coll Cardiol       Date:  1998-02       Impact factor: 24.094

5.  Percutaneous septal ablation for hypertrophic cardiomyopathy and mid-ventricular obstruction.

Authors:  H Seggewiss; L Faber
Journal:  Eur J Echocardiogr       Date:  2000-12

6.  Mid-cavity obstruction in apical hypertrophy: Doppler evidence of diastolic intraventricular gradient with higher apical pressure.

Authors:  W A Zoghbi; R N Haichin; M A Quinones
Journal:  Am Heart J       Date:  1988-12       Impact factor: 4.749

7.  Appraisal of dual-chamber pacing therapy in hypertrophic cardiomyopathy: too soon for a rush to judgment?

Authors:  B J Maron
Journal:  J Am Coll Cardiol       Date:  1996-02       Impact factor: 24.094

8.  Midventricular obstruction--a form of hypertrophic obstructive cardiomyopathy--and systolic anterior motion of the mitral valve.

Authors:  A Sheikhzadeh; B Eslami; U Stierle; A F Langbehn; K W Diederich
Journal:  Clin Cardiol       Date:  1986-12       Impact factor: 2.882

Review 9.  Hypertrophic obstructive cardiomyopathy: mechanism of obstruction and response to therapy.

Authors:  Danita M Yoerger; Arthur E Weyman
Journal:  Rev Cardiovasc Med       Date:  2003       Impact factor: 2.930

10.  Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy. Significance in producing left ventricular outflow obstruction.

Authors:  H G Klues; W C Roberts; B J Maron
Journal:  Circulation       Date:  1991-09       Impact factor: 29.690

View more
  3 in total

Review 1.  Mid-ventricular obstructive hypertrophic cardiomyopathy with apical aneurysm: An important subtype of arrhythmogenic cardiomyopathy.

Authors:  Li Cui; Gary Tse; Zhiqiang Zhao; George Bazoukis; Konstantinos P Letsas; Panagiotis Korantzopoulos; Leonardo Roever; Guangping Li; Tong Liu
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-02-09       Impact factor: 1.468

2.  Mid-ventricular obstructive hypertrophic cardiomyopathy associated with an apical aneurysm: evaluation of possible causes of aneurysm formation.

Authors:  Yuichi Sato; Naoya Matsumoto; Shinro Matsuo; Shunichi Yoda; Shigemasa Tani; Yuji Kasamaki; Tadateru Takayama; Satoshi Kunimoto; Satoshi Saito
Journal:  Yonsei Med J       Date:  2007-10-31       Impact factor: 2.759

3.  Mid-ventricular hypertrophic obstructive cardiomyopathy presenting with acute myocardial infarction.

Authors:  Yuichi Sato; Naoya Matsumoto; Shinro Matsuo; Shunichi Yoda; Satoshi Kunimoto; Satoshi Saito
Journal:  Tex Heart Inst J       Date:  2007
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.